Twice Daily Treatment With Amoxicillin for Non-severe Community Acquired Pneumonia.
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The aim of this study will be to evaluate whether a twice-daily antibiotic regimen is
non-inferior to a thrice-daily regimen for the treatment of non-severe community acquired
pneumonia in children presenting at a paediatric Emergency Department (ED).